ArticleFrontiers in pharmacology2026

Chalcone-containing dual-targeting PD-L1/tubulin small molecules: a novel approach for cancer immunotherapy.

Yingxing Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.